Marengo Advances TriSTAR Pipeline with Ipsen Collaboration
Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTARâ„¢ collaboration with Ipsen,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTARâ„¢ collaboration with Ipsen,...
New York, New York, August 4, 2026 Nuvation Bio has announced that it will present new subgroup analyses from...
Irvine, California, August 4, 2026 Allergan Aesthetics, an AbbVie company, has announced that the U.S. Food and Drug Administration...
DALLAS, July 22, 2026 Cosmetic Physician Partners (CPP) has announced a $35 million capital distribution to its practitioner-shareholders, marking...
BOSTON, Massachusetts, June 30, 2026 Skyhawk Therapeutics has announced encouraging 12-month interim results from its ongoing Phase 1/2 clinical...
SUZHOU, China, and MÖLNDAL, Sweden, July 2, 2026 Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals...
FORT MYERS, Florida, July 2, 2026 Trilogy Laboratories has announced the acquisition of YNS Cosmeceuticals, a respected skincare brand...
SEATTLE, July 1, 2026 SkinSpirit, a leading U.S. provider of medical aesthetic treatments, has expanded its regenerative aesthetics portfolio...
BARCELONA, Spain, June 17, 2026 Skin Tech Pharma Group has announced that its flagship injectable treatment, RRS® HA LONG...
IRVINE, Calif., June 16, 2026 Allergan Aesthetics, an AbbVie company, has received U.S. Food and Drug Administration (FDA) approval...
